AMPH Stock: Price, Earnings History and SEC Filings
Amphastar Pharmaceuticals, Inc. (AMPH) last traded at $27.72, up 2.93% on the latest session and up 7.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.80 against an analyst estimate of $0.51, a beat of 56.9%.
$27.72 +2.93%
1 month+7.40%
52-week high$29.52
52-week low$16.65
Volume664,507
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AMPH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.80 | $0.51 | +56.86% |
| Mar 2026 | May 7, 2026 | $0.26 | $0.62 | -58.06% |
| Dec 2025 | Feb 26, 2026 | $0.61 | $0.89 | -31.46% |
| Sep 2025 | Nov 6, 2025 | $0.83 | $0.73 | +13.70% |
AMPH beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
AMPH financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $720M | $98M | $121M | 13.6% | $2.03 |
| 2024 | $732M | $160M | $172M | 21.8% | $3.06 |
| 2023 | $644M | $138M | $145M | 21.3% | $2.60 |
| 2022 | $499M | $91M | $65M | 18.3% | $1.74 |
| 2021 | $438M | $62M | $71M | 14.2% | $1.25 |
| 2020 | $350M | $1M | $23M | 0.4% | $0.03 |
| 2019 | $322M | $49M | $207000 | 15.2% | $0.98 |
| 2018 | $295M | -$6M | -$9M | -1.9% | $-0.12 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for AMPH
SEC filing data is not available right now. You can search for AMPH on SEC EDGAR.
AMPH news
- 3 profitable stocks with warning signsOct 30, 2026 · finance.yahoo.com
- BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out forOct 29, 2026 · finance.yahoo.com
- Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026Oct 29, 2026 · finance.yahoo.com
- 3 value stocks that fall shortOct 29, 2026 · finance.yahoo.com
- Analysts Estimate Alps Alpine Co Ltd. - Unsponsored ADR (APELY) to Report a Decline in Earnings: What to Look Out forOct 29, 2026 · msn.com
- Bausch Health (BHC) Surpasses Q3 Earnings and Revenue EstimatesOct 28, 2026 · finance.yahoo.com
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. (AMPH) is a US-listed public company on Nasdaq.